Jinhai Medical Technology (HKSE:02225) Other Financing: HK$155.7 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02225 Jinhai Medical Technology Ltd HKSE:02225
61 GF Score
Price HK$6.11
GF Value HK$1.41
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Jinhai Medical Technology Other Financing?

Jinhai Medical Technology HKSE:02225 -6.22% 61 Other Financing is HK$155.7 Mil as of Dec. 2025. GuruFocus rates HKSE:02225 with a GF Score™ of 61/100 and a GF Value™ of HK$1.41 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Jinhai Medical Technology's Other Financing for the six months ended in Dec. 2025 was HK$157.9 Mil.

Jinhai Medical Technology's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was HK$155.7 Mil.

Jinhai Medical Technology Other Financing Historical Data

* Premium members only.

The historical data trend for Jinhai Medical Technology's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jinhai Medical Technology Other Financing Chart

Jinhai Medical Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.76 0.63 -0.94 -2.04 -4.07

Jinhai Medical Technology Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.01 -0.04 -2.14 157.86 0.00
HKSE:02225
61GF Score
Jinhai Medical Technology Ltd HKSE:02225
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jinhai Medical Technology Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$155.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of HK$155.7 Mil mean?
Jinhai Medical Technology (HKSE:02225) has a Other Financing of HK$155.7 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Jinhai Medical Technology and its competitors.
Is Jinhai Medical Technology's Other Financing too high?
Jinhai Medical Technology's current Other Financing is HK$155.7 Mil. Overall, Jinhai Medical Technology has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jinhai Medical Technology's Other Financing compare to RHI and KFY?
Jinhai Medical Technology's Other Financing of HK$155.7 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Conglomerates company?
A good Other Financing depends on the Conglomerates industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Jinhai Medical Technology and its competitors. Jinhai Medical Technology's current Other Financing is HK$155.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinhai Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Jinhai Medical Technology (HKSE:02225) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$1.41, compared to a current price of HK$6.11 — trading 333% above its estimated fair value. The current Other Financing is HK$155.7 Mil. Jinhai Medical Technology's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Jinhai Medical Technology (HKSE:02225), the current Other Financing is HK$155.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jinhai Medical Technology (HKSE:02225) Overvalued in 2026?

Based on GuruFocus' analysis, Jinhai Medical Technology stock appears to be overvalued. The current stock price of HK$6.11 is trading 333% above its estimated GF Value™ of HK$1.41. GuruFocus considers Jinhai Medical Technology to be Significantly Overvalued.

Key valuation signals for HKSE:02225:

  • Other Financing: HK$155.7 Mil
  • GF Value™: HK$1.41 vs. price of HK$6.11 (333% above fair value)
  • GF Score™: 61/100 with 9 warning signs

No single metric tells the full story. See the HKSE:02225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jinhai Medical Technology Business Description

Address 1275 Meichuan Road, 3rd Floor, Block East, Putuo District, Shanghai, CHN
Jinhai Medical Technology Ltd is an investment holding company. Along with its subsidiaries, it is principally engaged in providing medical equipment in China and manpower outsourcing and ancillary services to building and construction contractors in Singapore. The group also provides IT services, construction ancillary services (which comprise warehousing, cleaning, and building maintenance works), and dormitory services in Singapore. It generates maximum revenue from the sale of minimally invasive surgery solutions, medical products, and related services in the People's Republic of China.
61GF Score

Get the complete analysis for HKSE:02225

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$6.11
Price
HK$1.41
GF Value